Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans

Blood

Volumn 102, Issue 1, 2003, Pages 388-393

  James, Edward ^b   Chai, Jian Guo ^b   Dewchand, Hamlata ^b   Macchiarulo, Eugenio ^b   Dazzi, Francesco ^b   Simpson, Elizabeth ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; HY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN; PEPTIDE; REAGENT;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXIC T LYMPHOCYTE; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE CLONE; LYMPHOCYTE CULTURE; MALE; MOUSE; MULTIPARA; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; STEM CELL TRANSPLANTATION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0037902059     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-10-3170     Document Type: Article

References (38)

1. Goldman JM, Gale RP, Horowitz MM, et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk for relapse associated with T-cell depletion. Ann Intern Med. 1988;108:806-814.
2. Dazzi F, Szydlo RM, Goldman JM. Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneie stem cell transplant: where we now stand. Exp Hematol. 1999;27:1477-1486.
3. Simpson E, Scott D, James E, et al. Minor histocompatibility antigens: genes and peptides. Eur J Immunogenet. 2001;28:505-513.
4. Advisory Committee on the International Bone Marrow Transplant Registry. Report from the International Bone Marrow Transplant Registry. Bone Marrow Transplant. 1989;4:221-228.
5. Gratwohl A, Hermans J, Niederwieser D, et al. Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants. Hematol J. 2001;2:363-370.
6. de-Bueger M, Bakker A, Van-Rood JJ, Van-der-Woude F, Goulmy E. Tissue distribution of human minor histocompatibility antigens: ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol. 1992;149:1788-1794.
7. Tseng LH, Lin MT, Hansen JA, et al. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation. Blood. 1999;94:2911-2914.
8. Dazzi F, Szydlo RM, Craddock C, et al. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia. Blood. 2000;95:67-71.
9. Dazzi F, Szydlo R, Apperley J, Goldman JM. Prognostic factors for acute graft versus hosl disease after donor lymphocyte infusions. Blood. 2002;100:2673-2674.
10. Flowers ME, Pepe MS, Longton G, et al. Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation. Br J Haematol. 1990;74:492-496.
11. Atkinson K, Farrell C, Chapman G, et al. Female marrow donors increase the risk of acute graft-versus-host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum. Br J Haematol. 1986;63:231-239.
12. Kollman C, Howe CW, Anasetti C, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 2001;98:2043-2051.
13. Simpson E, Scott D, Chandler P. The male-specific histocompatibility antigen, H-Y: a history of transplantation, immune response genes, sex determination and expression cloning. Annu Rev Immunol. 1997;15:39-61.
14. Greenfield A, Scott D, Pennisi D, et al. An H-YDb epitope is encoded by a novel mouse Y chromosome gene. Nat Genet. 1996;14:474-478.
15. Markiewicz MA, Girao C, Opferman JT, et al. Long-term T cell memory requires the surface expression of self-peptide/major histocompatibility complex molecules. Proc Natl Acad Sci U S A. 1998;95:3065-3070.
16. Scott D, Addey C, Ellis P, et al. Dendritic cells permit identification of genes encoding MHC class II-restricted epitopes of transplantation antigens. Immunity. 2000;12:711-720.
17. Millrain M, Chandler P, Dazzi F, et al. Examination of HY response: T cell expansion, immunodominance and cross-priming revealed by HY tetramer analysis. J Immunol. 2001;167:3756-3764.
18. Billingham RE. A second study on the H-Y transplantation antigen in mice. Proc R Soc Lond B Biol Sci. 1966;163:61-89.
19. Simpson E, Benjamin D, Chandler P. Nonresponsiveness to H-Y: tolerance in H-2b mice. Transplant Proc. 1981;13:1880-1883.
20. Weissman IL. Transfer of tolerance. Transplantation. 1973;15:265-269.
21. Waldmann H, Cobbold S. How do monoclonal antibodies induce tolerance? A role for infectious tolerance? Annu Rev Immunol. 1998;16:619-644.
22. Billingham RE. The technique of free skin grafting in mammals. J Exp Biol. 1951;28:385-402.
23. Altman JD, Moss PAH, Goulder PJR, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996;274:94-96.
24. Bailey DW. Genetics of histocompatibility in mice, I: new loci and congenic lines. Immunogenetics. 1975;2:249-275.
25. James E, Scott D, Chai J-G, et al. HY peptides modulate transplantation responses to skin allografts. Int Immunol. 2002;14:1333-1342.
26. Weinstein L. Irregular antibodies causing hemolytic disease of the newborn: a continuing problem. Clin Obstet Gynecol. 1982;25:321-332.
27. Jonker M, van Rood JJ. Inhibition of the mixed leukocyte reaction by alloantisera in man, I: technical aspects. Tissue Antigens. 1977;9:231-245.
28. Medawar PB. Some immunological and endocrinological problems raised by evolution of viviparity in vertebrates. Symp Soc Exp Biol. 1953;7:320-328.
29. Loke YW, King A, Burrows TD. Decidua in human implantation. Hum Reprod. 1995;10(suppl 2):14-21.
30. Navarro F, Llano M, Bellon T, et al. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol. 1999;29:277-283.
31. Munn DH, Zhou M, Attwood JT, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism [see comments]. Science. 1998;281:1191-1193.
32. + T-cells specific for paternal MHC class I accumulate during pregnancy. J Reprod Immunol. 1998;40:47-62.
33. Tafuri A, Alferink J, Moller P, Hammerling GJ, Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science. 1995;270:630-633.
34. + T lymphocytes that persist after peripheral tolerance to a self antigen expressed in the pancreas. J Immunol. 2000;164: 191-200.
35. Hammerling GJ, Schonrich G, Momburg F, et al. Non-deletional mechanisms of peripheral and central tolerance: studies with transgenic mice with tissue-specific expression of a foreign MHC class I antigen. Immunol Rev. 1991; 122:47-67.
36. Fontaine P, Roy-Proulx G, Knafo L, et al. Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease. Nat Med. 2001;7:789-794.
37. Mutis T, Gillespie G, Schrama E, et al. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat Med. 1999;5:839-842.
38. Dickinson AM, Wang X-N, Sviland L, et al. In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nat Med. 2002;8:410-414.